Salivary Gland Diseases
Welcome,         Profile    Billing    Logout  
 41 Companies   50 Products   50 Products   53 Mechanisms of Action   1 Trial   299 News 


123456»
  • ||||||||||  Trial completion, Enrollment change, Trial completion date, Trial primary completion date:  A Study of Flt3-Ligand Levels in Sj (clinicaltrials.gov) -  Apr 24, 2019   
    P=N/A,  N=30, Completed, 
    Active, not recruiting --> Completed | Trial completion date: May 2019 --> Jul 2018 Recruiting --> Completed | N=50 --> 30 | Trial completion date: Dec 2019 --> Apr 2019 | Trial primary completion date: Dec 2019 --> Apr 2019
  • ||||||||||  NN1213 / Novo Nordisk
    Biomarker, Trial completion:  Salivary Biomarkers for Sj (clinicaltrials.gov) -  Apr 20, 2019   
    P=N/A,  N=420, Completed, 
    Recruiting --> Completed | N=50 --> 30 | Trial completion date: Dec 2019 --> Apr 2019 | Trial primary completion date: Dec 2019 --> Apr 2019 Active, not recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  NeuroSenSS: Primary Sj (clinicaltrials.gov) -  Jan 11, 2019   
    P=N/A,  N=44, Completed, 
    N=18 --> 34 | Trial completion date: Dec 2018 --> May 2019 Recruiting --> Completed
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion, Trial completion date:  NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy (clinicaltrials.gov) -  Dec 11, 2018   
    P=N/A,  N=32, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Apr 2017 --> Jul 2017
  • ||||||||||  dexamethasone / Generic mfg.
    Trial termination:  Dexamethasone Irrigation of the Parotid Glands in Primary Sj (clinicaltrials.gov) -  Nov 2, 2018   
    P2,  N=14, Terminated, 
    Active, not recruiting --> Completed | Trial completion date: Apr 2017 --> Jul 2017 Completed --> Terminated; Slow enrollment
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Multi-Colored Placido Disk Viability (clinicaltrials.gov) -  Oct 5, 2018   
    P=N/A,  N=16, Completed, 
    Phase classification: P=N/A --> P2 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change:  Salivary Evaluation in Healthy Volunteers (clinicaltrials.gov) -  Sep 24, 2018   
    P=N/A,  N=173, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | N=250 --> 173
  • ||||||||||  Trial completion date, Trial primary completion date:  A Study of Flt3-Ligand Levels in Sj (clinicaltrials.gov) -  Aug 14, 2018   
    P=N/A,  N=50, Recruiting, 
    Active, not recruiting --> Completed Trial completion date: Dec 2017 --> Dec 2019 | Trial primary completion date: Dec 2017 --> Dec 2019
  • ||||||||||  NN1213 / Novo Nordisk
    Phase classification:  Salivary Evaluation in Healthy Volunteers (clinicaltrials.gov) -  Mar 30, 2018   
    P,  N=250, Recruiting, 
    Trial completion date: Apr 2018 --> Dec 2018 Phase classification: P=N/A --> P
  • ||||||||||  Halaven (eribulin mesylate) / Eisai
    Trial completion, Trial completion date, Metastases:  Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer (clinicaltrials.gov) -  Feb 22, 2018   
    P2,  N=29, Completed, 
    Active, not recruiting --> Completed | Trial completion date: Oct 2017 --> Oct 2017 Active, not recruiting --> Completed | Trial completion date: Feb 2018 --> Aug 2017
  • ||||||||||  Enrollment change, Trial withdrawal, Trial primary completion date:  Examining the Immunological Process of Autoimmune Patients (clinicaltrials.gov) -  Aug 8, 2017   
    P=N/A,  N=0, Withdrawn, 
    Trial primary completion date: Dec 2017 --> May 2017 N=200 --> 0 | Suspended --> Withdrawn | Trial primary completion date: Jul 2017 --> Aug 2016
  • ||||||||||  Trial primary completion date:  A Study of Flt3-Ligand Levels in Sj (clinicaltrials.gov) -  Jul 5, 2017   
    P=N/A,  N=50, Recruiting, 
    Trial primary completion date: Jul 2017 --> Feb 2018 Trial primary completion date: Jun 2017 --> Dec 2017
  • ||||||||||  dexamethasone / Generic mfg.
    Trial completion:  Dexamethasone Irrigation of the Parotid Glands in Primary Sj (clinicaltrials.gov) -  Apr 19, 2017   
    P2,  N=14, Completed, 
    Trial primary completion date: Dec 2016 --> Dec 2017 Enrolling by invitation --> Completed
  • ||||||||||  Biomarker, Enrollment closed:  Salivary Biomarkers for Sj (clinicaltrials.gov) -  Feb 6, 2017   
    P=N/A,  N=420, Active, not recruiting, 
    Not yet recruiting --> Completed | Phase classification: P2 --> PN/A | Trial primary completion date: Mar 2015 --> Sep 2016 Enrolling by invitation --> Active, not recruiting
  • ||||||||||  Orencia (abatacept) / BMS
    Trial primary completion date:  Abatacept for Patients With Inflammatory Arthritis Associated With Sj (clinicaltrials.gov) -  Jan 9, 2017   
    P2,  N=0, Withdrawn, 
    Phase classification: P2 --> P2a | Trial primary completion date: Feb 2017 --> Jul 2017 Trial primary completion date: Apr 2015 --> Oct 2014
  • ||||||||||  carboplatin / Generic mfg., amifostine / Generic mfg., paclitaxel / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date, Metastases:  Randomized Amifostine For SCCHN (clinicaltrials.gov) -  Jan 4, 2017   
    P2,  N=58, Completed, 
    Trial primary completion date: Apr 2015 --> Oct 2014 Active, not recruiting --> Completed | N=90 --> 58 | Trial primary completion date: Jun 2009 --> Jun 2007
  • ||||||||||  Trial primary completion date:  Multi-Colored Placido Disk Viability (clinicaltrials.gov) -  Oct 3, 2016   
    P=N/A,  N=20, Active, not recruiting, 
    N=100 --> 13 | Recruiting --> Terminated | Trial primary completion date: Oct 2009 --> Mar 2011; poor recruitment Trial primary completion date: Sep 2016 --> Sep 2018
  • ||||||||||  gefitinib / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date, Metastases:  Iressa Study in Patients With Salivary Gland Cancer (clinicaltrials.gov) -  Sep 23, 2016   
    P2,  N=37, Completed, 
    No longer recruiting --> Completed Active, not recruiting --> Completed | N=80 --> 37 | Trial primary completion date: Nov 2017 --> Sep 2016
  • ||||||||||  Enrollment closed, Trial primary completion date:  NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy (clinicaltrials.gov) -  Sep 14, 2016   
    P=N/A,  N=32, Active, not recruiting, 
    Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Apr 2017
  • ||||||||||  Trial primary completion date:  NeuroSenSS: Primary Sj (clinicaltrials.gov) -  Aug 22, 2016   
    P=N/A,  N=55, Recruiting, 
    Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2014 --> Apr 2017 Trial primary completion date: Sep 2015 --> Sep 2016
  • ||||||||||  Enrollment change, Trial termination, Trial primary completion date:  Effects of Sustained Reading on the Ocular Surface (clinicaltrials.gov) -  Aug 22, 2016   
    P=N/A,  N=34, Terminated, 
    Trial primary completion date: Sep 2015 --> Sep 2016 N=50 --> 34 | Suspended --> Terminated | Trial primary completion date: Dec 2016 --> Jun 2016; PI is moving to a different institution.
  • ||||||||||  Trial primary completion date:  A Study of Flt3-Ligand Levels in Sj (clinicaltrials.gov) -  Aug 10, 2016   
    P=N/A,  N=50, Recruiting, 
    N=50 --> 34 | Suspended --> Terminated | Trial primary completion date: Dec 2016 --> Jun 2016; PI is moving to a different institution. Trial primary completion date: Jun 2016 --> Jun 2017